Nautilus Biotechnology annual depreciation and amortization
2020
2021
2022
2023
2024
2025
Nautilus Biotechnology Depreciation & Amortization Growth & History (NAUT)
Nautilus Biotechnology's depreciation and amortization was $1.7M for fiscal 2025.
View full Nautilus Biotechnology company overviewNautilus Biotechnology annual depreciation and amortization history
| Fiscal year | Period ended | Depreciation and amortization | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $1.7M | −$300,000 | −15.00% |
| 2024 | 2024-12-31 | $2.0M | $151,000 | +8.17% |
| 2023 | 2023-12-31 | $1.8M | $632,000 | +51.93% |
| 2022 | 2022-12-31 | $1.2M | $198,000 | +19.43% |
| 2021 | 2021-12-31 | $1.0M | $309,000 | +43.52% |
| 2020 | 2020-12-31 | $710,000 | — | — |
Nautilus Biotechnology quarterly depreciation and amortization
Q2.20
Q3.20
Q1.21
Q2.21
Q3.21
Q1.22
Q2.22
Q3.22
Q1.23
Q2.23
Q3.23
Q1.24
Q2.24
Q3.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Depreciation and amortization | Change | YoY change |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $1.3M | $884,000 | +221.00% |
| Q1 2026 | 2026-03-31 | $334,000 | −$131,000 | −28.17% |
| Q4 2025 | 2025-12-31 | $1.6M | — | — |
| Q3 2025 | 2025-09-30 | $400,000 | −$100,000 | −20.00% |
| Q2 2025 | 2025-06-30 | $400,000 | −$100,000 | −20.00% |
| Q1 2025 | 2025-03-31 | $465,000 | −$51,000 | −9.88% |
| Q3 2024 | 2024-09-30 | $500,000 | $0 | 0.00% |
| Q2 2024 | 2024-06-30 | $500,000 | $100,000 | +25.00% |
| Q1 2024 | 2024-03-31 | $516,000 | $131,000 | +34.03% |
| Q3 2023 | 2023-09-30 | $500,000 | $200,000 | +66.67% |
| Q2 2023 | 2023-06-30 | $400,000 | $100,000 | +33.33% |
| Q1 2023 | 2023-03-31 | $385,000 | $104,000 | +37.01% |
| Q3 2022 | 2022-09-30 | $300,000 | $0 | 0.00% |
| Q2 2022 | 2022-06-30 | $300,000 | $0 | 0.00% |
| Q1 2022 | 2022-03-31 | $281,000 | $67,000 | +31.31% |
| Q3 2021 | 2021-09-30 | $300,000 | $100,000 | +50.00% |
| Q2 2021 | 2021-06-30 | $300,000 | $100,000 | +50.00% |
| Q1 2021 | 2021-03-31 | $214,000 | — | — |
| Q3 2020 | 2020-09-30 | $200,000 | — | — |
| Q2 2020 | 2020-06-30 | $200,000 | — | — |
Nautilus Biotechnology depreciation and amortization trends
Over the last five fiscal years, Nautilus Biotechnology's depreciation and amortization increased from $710,000 to $1.7M, a change of $990,000. The latest reported quarter, Q2 2026, shows $1.3M.
About the metric
What depreciation and amortization mean
Depreciation and amortization allocate the cost of tangible and intangible assets over their useful lives. These non-cash expenses reduce reported earnings and are commonly added back when calculating EBITDA and operating cash flow.
Calculation and source
Reported depreciation and amortization
TickerStat uses a combined depreciation and amortization value when reported. If a company reports the two components separately for an aligned period, they are added together without duplicating overlapping facts. Fiscal periods can differ from calendar years, so exact period-end dates are included.
Review Nautilus Biotechnology source filings ↗